This inventor holds 1 USPTO granted patent. Top assignees: Shanghai Aryl Pharmtech Co., Ltd., Zhejiang Hisun Pharmaceutical Co., Ltd.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 4 
1 out of 5 Years Active: 2026
Title: Linjiang Shao: Inventor of a Quinazoline Derivative Patent.
Introduction
Linjiang Shao is an inventor based in Taizhou, China. His patent work includes a pharmaceutical invention concerning substituted quinazoline derivatives and their potential use as SOS1 inhibitors.
Latest Patents
Shao is associated with 1 patent, titled “Quinazoline Derivative, or Preparation Method Therefor and Use Thereof.” The invention describes a substituted quinazoline derivative, methods for preparing it, pharmaceutically acceptable salts, and pharmaceutical compositions containing the derivative. It also addresses the use of the derivative or its compositions as therapeutic agents, particularly as SOS1 inhibitors.
Career Highlights
Shao has been associated with Zhejiang Hisun Pharmaceutical Co., Ltd. and Shanghai Aryl Pharmtech Co., Ltd. His patent reflects work in pharmaceutical chemistry and the development of potential therapeutic compounds.
Collaborations
Shao’s named coworkers include Panpan Zhang and Chaoying Cheng.
Conclusion
Linjiang Shao’s patent focuses on substituted quinazoline compounds, their preparation, and their potential therapeutic application as SOS1 inhibitors.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile